Stay updated on ECT-Pembrolizumab for Unresectable Melanoma Clinical Trial

Sign up to get notified when there's something new on the ECT-Pembrolizumab for Unresectable Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ECT-Pembrolizumab for Unresectable Melanoma Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Updated revision tag from v3.5.3 to v3.5.4, indicating a newer version of the page metadata.
    Difference
    0.1%
    Check dated 2026-05-15T04:13:59.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    Revision tag updated from v3.5.2 to v3.5.3, indicating a small update to the page's revision history and release notes.
    Difference
    0.1%
    Check dated 2026-04-30T18:34:41.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-16T10:47:33.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    Layout and formatting updates to the study record page were observed. Core study content like eligibility criteria, outcomes, and enrollment status remains unchanged.
    Difference
    0.1%
    Check dated 2026-03-25T21:00:33.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-18T15:53:37.000Z thumbnail image
  8. Check
    78 days ago
    Change Detected
    Summary
    Revision tag on the page updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T14:16:32.000Z thumbnail image

Stay in the know with updates to ECT-Pembrolizumab for Unresectable Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ECT-Pembrolizumab for Unresectable Melanoma Clinical Trial page.